Broad Institute of MIT and Harvard is empowering a revolution in biomedicine to accelerate the pace at which the world conquers disease
Propelling the understanding and treatment of disease
Promoting inclusion
Broad Institute believes that progress in biomedical research requires a fully inclusive community across sex, race, ethnicity, sexual orientation, age, disability, and gender identity
Building partnerships
Broad Institute works to build and sustain international consortia to speed discovery in areas including psychiatric research, infectious disease, cardiovascular disease, and cancer
Empowering scientists
Broad Institute fosters an environment in which scientists can take risks on bold ideas with transformative potential
Reaching globally
Broad Institute is committed to addressing medical challenges across the world, including collaborating with scientists and public health experts to address important needs in developing countries
Collaborating deeply
Broad Institute is a mission-driven community that brings together researchers in medicine, biology, chemistry, computation, engineering, and mathematics from across MIT, Harvard, and Harvard-affiliated hospitals, along with collaborators around the world
Responding to COVID19
INSIDE BROAD
News / 08.18.22
A study of more than 150,000 people increases the number of genes linked to autism and neurodevelopmental disorders and explores their impact on brain development.Read more
News / 08.15.22
Researchers talk about how their Operation Outbreak app can help colleges respond to outbreaks.Read more
News / 08.15.22
Genebass summarizes a genetic analysis of nearly 400,000 people in the UK Biobank and could help researchers identify new therapeutic targets.Read more
News / 08.11.22
Prokaryotes can detect hallmark viral proteins and trigger cell death through a process seen across all domains of life.Read more
News / 08.10.22
New study shows how microglia are prompted to change their state to adapt to different areas of the brainRead more
News / 08.4.22
New map of chronic lymphocytic leukemia could potentially help identify new diagnostic markers, offer more accurate prognoses, and develop novel treatments.Read more
News / 08.2.22
Anne Carpenter and Shantanu Singh discuss how they are expanding the uses of their image-based profiling method, Cell Painting, to speed up drug discovery and predict gene function.Read more
News / 07.26.22
Study finds a single molecule made by a gut bacterium that helps moderate immune responses.Read more
News / 07.21.22
The gene, FOXR2, is normally active only in the testis, and is now a potential drug target across cancers.Read more
News / 07.13.22
Scientists have solved the structure of an important complex of RAS-pathway proteins, explaining how known mutations lead to disease and suggesting potential new binding sites for cancer drugs.Read more
News / 07.13.22
A Broad scientist discusses a new effort to identify oft-missed protein-coding sequences in the human genome called non-canonical open reading frames, which could yield insights into disease and what makes humans unique.Read more
Spotlight / 08.3.22
Heidi Rehm explains how genomics researchers are leveraging vast amounts of genomic data to find the causes for some of the rarest diseases.Read more
Spotlight / 05.21.20
Learn about COVID-19 clinical testing and research activities at Broad, as well as data and resources for scientists studying COVID-19.Read more
Blog / 03.21.22
An MD/PhD student discusses what drew her to combining computational biology with ophthalmology and cardiovascular medicine, and her work inspiring high school girls in science and engineering.Read more